These comprised indicators of poor glycaemic control (HbA1c 7.0%), adverse lipid profile (HDL 5.2%, high cholesterol 4.1%), hypertension (8.4%) and systemic inflammation (CRP 6.4%). This evidence concerns the gene CRP and hypertensive disorder.